Advanced search
Add to list

Differential effects of 5-hydroxytryptamine(4) receptor agonists at gastric versus cardiac receptors: An operational framework to explain and quantify organ-specific behavior

Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
De Maeyer, Joris, et al. “Differential Effects of 5-Hydroxytryptamine(4) Receptor Agonists at Gastric versus Cardiac Receptors: An Operational Framework to Explain and Quantify Organ-Specific Behavior.” JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 317, no. 3, AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS, 2006, pp. 955–64.
APA
De Maeyer, J., PRINS, N., SCHUURKES, J., & Lefebvre, R. (2006). Differential effects of 5-hydroxytryptamine(4) receptor agonists at gastric versus cardiac receptors: An operational framework to explain and quantify organ-specific behavior. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 317(3), 955–964.
Chicago author-date
De Maeyer, Joris, NH PRINS, JAJ SCHUURKES, and Romain Lefebvre. 2006. “Differential Effects of 5-Hydroxytryptamine(4) Receptor Agonists at Gastric versus Cardiac Receptors: An Operational Framework to Explain and Quantify Organ-Specific Behavior.” JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 317 (3): 955–64.
Chicago author-date (all authors)
De Maeyer, Joris, NH PRINS, JAJ SCHUURKES, and Romain Lefebvre. 2006. “Differential Effects of 5-Hydroxytryptamine(4) Receptor Agonists at Gastric versus Cardiac Receptors: An Operational Framework to Explain and Quantify Organ-Specific Behavior.” JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 317 (3): 955–964.
Vancouver
1.
De Maeyer J, PRINS N, SCHUURKES J, Lefebvre R. Differential effects of 5-hydroxytryptamine(4) receptor agonists at gastric versus cardiac receptors: An operational framework to explain and quantify organ-specific behavior. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2006;317(3):955–64.
IEEE
[1]
J. De Maeyer, N. PRINS, J. SCHUURKES, and R. Lefebvre, “Differential effects of 5-hydroxytryptamine(4) receptor agonists at gastric versus cardiac receptors: An operational framework to explain and quantify organ-specific behavior,” JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 317, no. 3, pp. 955–964, 2006.
@article{356697,
  author       = {{De Maeyer, Joris and PRINS, NH and SCHUURKES, JAJ and Lefebvre, Romain}},
  issn         = {{0022-3565}},
  journal      = {{JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS}},
  language     = {{eng}},
  number       = {{3}},
  pages        = {{955--964}},
  publisher    = {{AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS}},
  title        = {{Differential effects of 5-hydroxytryptamine(4) receptor agonists at gastric versus cardiac receptors: An operational framework to explain and quantify organ-specific behavior}},
  volume       = {{317}},
  year         = {{2006}},
}

Web of Science
Times cited: